63. 特発性血小板減少性紫斑病 Idiopathic thrombocytopenic purpura Clinical trials / Disease details

臨床試験数 : 391 / 薬物数 : 235 - (DrugBank : 50) / 標的遺伝子数 : 49 - 標的パスウェイ数 : 139

3 trials found

diseases per page:

Showing 1 to 3 of 3 diseases

Filter by

No.	TrialID	Date_ enrollment	Date_ registration	Public_title	Scientific_title	Condition	Intervention	Primary_ sponsor	Secondary_ sponsor	Recruitment_ Status	Inclusion_ agemin	Inclusion_ agemax	Inclusion_ gender	Target_ size	Phase	Countries
1	NCT05562882 (ClinicalTrials.gov)	October 15, 2022	28/9/2022	A Clinical Trial to Assess Safety and Efficacy of Daratumumabin the Treatment of Primary Immune Thro ...	A Investigator-initiated Clinical Trial to Assess Safety and Efficacy of Daratumumabin the Treatment ...	Immune Thrombocytopenia	Drug: Daratumumab Injection	Institute of Hematology & Blood Diseases Hospital	NULL	Not yet recruiting	18 Years	N/A	All	20	Early Phase 1	NULL
2	EUCTR2019-004683-22-DK (EUCTR)	12/07/2022	17/05/2022	Daratumumab as a treatment for adult immune thrombocytopenia	Daratumumab as a treatment for adult immune thrombocytopenia - The DART-study	Immune thrombocytopenia MedDRA version: 23.0;Level: LLT;Classification code 10021245;Term: Idiopathi ...	Trade Name: Darzalex Product Name: Daratumumab Product Code: L01FC01 INN or Proposed INN: DARATUMUMAB Ot ...	Ostfold Hospital Trust	NULL	Authorised-recruitment may be ongoing or finished			Female: yes Male: yes	21	Phase 2	Denmark;Norway
3	EUCTR2019-004683-22-NO (EUCTR)	16/10/2020	29/04/2020	Daratumumab as a treatment for adult immune thrombocytopenia	Daratumumab as a treatment for adult immune thrombocytopenia - The DART-study	Immune thrombocytopenia MedDRA version: 23.0;Level: LLT;Classification code 10021245;Term: Idiopathi ...	Product Name: daratumumab INN or Proposed INN: DARATUMUMAB Other descriptive name: HUMAX-CD38	Ostfold Hospital Trust	NULL	Authorised-recruitment may be ongoing or finished			Female: yes Male: yes	20	Phase 2	Norway

First Previous1Next Last